(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.14% $ 5.32
@ $6.92
Выпущен: 14 февр. 2024 @ 22:05
Доходность: -23.07%
Предыдущий сигнал: февр. 14 - 17:30
Предыдущий сигнал:
Доходность: -1.07 %
Live Chart Being Loaded With Signals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally...
Stats | |
---|---|
Объем за сегодня | 512 701 |
Средний объем | 920 458 |
Рыночная капитализация | 392.60M |
EPS | $0 ( 2024-02-27 ) |
Дата следующего отчета о доходах | ( $0.0400 ) 2024-05-08 |
Last Dividend | $1.600 ( 1998-01-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 7.39 |
ATR14 | $0.00300 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-26 | Datin James A | Buy | 3 217 | Common Stock |
2024-03-26 | Datin James A | Sell | 871 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Buy | 58 759 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Sell | 5 616 | Common Stock |
2024-03-01 | Anthony Michele Marie | Buy | 24 336 | Common Stock |
INSIDER POWER |
---|
67.93 |
Last 97 transactions |
Buy: 2 719 008 | Sell: 297 058 |
Объем Корреляция
OraSure Technologies Inc Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
OraSure Technologies Inc Корреляция - Валюта/Сырье
OraSure Technologies Inc Финансовые показатели
Annual | 2023 |
Выручка: | $405.47M |
Валовая прибыль: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2023 |
Выручка: | $405.47M |
Валовая прибыль: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2022 |
Выручка: | $387.48M |
Валовая прибыль: | $147.64M (38.10 %) |
EPS: | $-0.250 |
FY | 2021 |
Выручка: | $233.67M |
Валовая прибыль: | $117.60M (50.33 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
OraSure Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.600 | 1998-01-08 |
Last Dividend | $1.600 | 1998-01-08 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1.600 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.02 | |
Div. Directional Score | 7.70 | -- |
Year | Amount | Yield |
---|---|---|
1998 | $1.600 | 29.80% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.35 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.111 | 1.200 | 6.30 | 7.56 | [0 - 0.3] |
returnOnEquityTTM | 0.132 | 1.500 | 9.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.77 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.36 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 7.35 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0280 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0314 | -1.500 | 9.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.425 | 1.000 | 6.26 | 6.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0901 | 1.000 | -0.198 | -0.198 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.840 | 0.800 | 7.73 | 6.19 | [0.5 - 2] |
Total Score | 11.37 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.29 | 1.000 | 9.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.132 | 2.50 | 9.77 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0486 | 1.500 | -3.01 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.286 | 1.000 | 5.36 | 0 | [0.1 - 0.5] |
Total Score | 4.02 |
OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа